These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16930101)

  • 1. A double-blind placebo-controlled randomised pilot study of nocturnal melatonin in tracheostomised patients.
    Ibrahim MG; Bellomo R; Hart GK; Norman TR; Goldsmith D; Bates S; Egi M
    Crit Care Resusc; 2006 Sep; 8(3):187-91. PubMed ID: 16930101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial.
    Bourne RS; Mills GH; Minelli C
    Crit Care; 2008; 12(2):R52. PubMed ID: 18423009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin reduces the need for sedation in ICU patients: a randomized controlled trial.
    Mistraletti G; Umbrello M; Sabbatini G; Miori S; Taverna M; Cerri B; Mantovani ES; Formenti P; Spanu P; D'Agostino A; Salini S; Morabito A; Fraschini F; Reiter RJ; Iapichino G
    Minerva Anestesiol; 2015 Dec; 81(12):1298-310. PubMed ID: 25969139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Melatonin Supplementation on Sleep Quality and Assessment of the Serum Melatonin in ICU Patients: A Randomized Controlled Trial.
    Gandolfi JV; Di Bernardo APA; Chanes DAV; Martin DF; Joles VB; Amendola CP; Sanches LC; Ciorlia GL; Lobo SM
    Crit Care Med; 2020 Dec; 48(12):e1286-e1293. PubMed ID: 33048904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for a prospective randomised double-blind placebo-controlled clinical trial investigating a Better Outcome with Melatonin compared to Placebo Administered to normalize sleep-wake cycle and treat hypoactive ICU Delirium: the Basel BOMP-AID study.
    Hollinger A; von Felten S; Sutter R; Huber J; Tran F; Reinhold S; Abdelhamid S; Todorov A; Gebhard CE; Cajochen C; Steiner LA; Siegemund M
    BMJ Open; 2020 Apr; 10(4):e034873. PubMed ID: 32354780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
    Singer C; Tractenberg RE; Kaye J; Schafer K; Gamst A; Grundman M; Thomas R; Thal LJ;
    Sleep; 2003 Nov; 26(7):893-901. PubMed ID: 14655926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial.
    Skrobik Y; Duprey MS; Hill NS; Devlin JW
    Am J Respir Crit Care Med; 2018 May; 197(9):1147-1156. PubMed ID: 29498534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There a Benefit to the Use of Melatonin in Preoperative Zygomatic Fractures?
    de Carvalho Nogueira EF; de Oliveira Vasconcelos R; Teixeira Correia SS; Souza Catunda I; Amorim JA; do Egito Cavalcanti Vasconcelos B
    J Oral Maxillofac Surg; 2019 Oct; 77(10):2017.e1-2017.e7. PubMed ID: 31260676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients.
    Mistraletti G; Paroni R; Umbrello M; D'Amato L; Sabbatini G; Taverna M; Formenti P; Finati E; Favero G; Bonomini F; Rezzani R; Reiter RJ; Iapichino G
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study.
    Al-Qadheeb NS; Skrobik Y; Schumaker G; Pacheco MN; Roberts RJ; Ruthazer RR; Devlin JW
    Crit Care Med; 2016 Mar; 44(3):583-91. PubMed ID: 26540397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disruption in tetraplegia: a randomised, double-blind, placebo-controlled crossover trial of 3 mg melatonin.
    Spong J; Kennedy GA; Tseng J; Brown DJ; Armstrong S; Berlowitz DJ
    Spinal Cord; 2014 Aug; 52(8):629-34. PubMed ID: 24891007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.
    Kapoor M; Storrar W; Balls L; Brown TP; Mansur A; Hedley E; Jones T; Roberts C; Shirkey B; Dutton S; Luengo-Fernandez R; Little M; Dewey A; Marshall S; Fogg C; Boughton K; Rahman N; Yu LM; Bradding P; Howarth P; Chauhan AJ
    Health Technol Assess; 2019 Jun; 23(29):1-140. PubMed ID: 31232684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial of melatonin after night-shift work: efficacy and neuropsychologic effects.
    Wright SW; Lawrence LM; Wrenn KD; Haynes ML; Welch LW; Schlack HM
    Ann Emerg Med; 1998 Sep; 32(3 Pt 1):334-40. PubMed ID: 9737496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial.
    Martinez FE; Anstey M; Ford A; Roberts B; Hardie M; Palmer R; Choo L; Hillman D; Hensley M; Kelty E; Murray K; Singh B; Wibrow B
    Trials; 2017 Jan; 18(1):4. PubMed ID: 28061873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed sleep phase syndrome: A placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset.
    Nagtegaal JE; Kerkhof GA; Smits MG; Swart AC; Van Der Meer YG
    J Sleep Res; 1998 Jun; 7(2):135-43. PubMed ID: 9682186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive effects of exogenous melatonin administration in elderly persons: a pilot study.
    Peck JS; LeGoff DB; Ahmed I; Goebert D
    Am J Geriatr Psychiatry; 2004; 12(4):432-6. PubMed ID: 15249281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial.
    Riemersma-van der Lek RF; Swaab DF; Twisk J; Hol EM; Hoogendijk WJ; Van Someren EJ
    JAMA; 2008 Jun; 299(22):2642-55. PubMed ID: 18544724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.